Australia markets open in 21 minutes

Anatara Lifesciences Ltd (ANR.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0480+0.0020 (+4.35%)
At close: 04:10PM AEST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Total revenue
-
-
-
-
-
663.405
Gross profit
-
-
-
-
-
663.405
Operating expenses
Research development
1,466
1,602
747.181
840.815
1,289
-
Selling general and administrative
730.783
891.44
1,376
1,620
1,991
-
Total operating expenses
2,888
3,285
3,022
3,113
4,206
-
Operating income or loss
-2,888
-3,285
-3,022
-3,113
-4,206
-
Interest expense
-
2.37
3.32
0.3
-
-
Total other income/expenses net
1,123
1,246
487.235
1,108
789.211
-
Income before tax
-1,747
-2,023
-2,532
-1,996
-3,365
-
Income tax expense
0
0
0
0
0
-
Income from continuing operations
-1,747
-2,023
-2,532
-1,996
-3,365
-
Net income
-1,747
-2,023
-2,532
-1,996
-3,365
-
Net income available to common shareholders
-1,747
-2,023
-2,532
-1,996
-3,365
-
Basic EPS
-0.02
-0.02
-0.03
-0.03
-0.06
-
Diluted EPS
-0.02
-0.02
-0.03
-0.03
-0.06
-
Basic average shares
104,303
104,303
78,218
68,953
54,616
-
Diluted average shares
104,303
104,303
78,218
68,953
54,616
-